Successful treatment of multidrug resistant Acinetobacter baumannii meningitis

J Infect Dev Ctries. 2007 Dec 1;1(3):342-4.

Abstract

Background: Acinetobacter baumannii is a major cause of nosocomial infections in many hospitals and appears to have a propensity for developing multiple antimicrobial resistance rapidly.

Cases: We report two cases with post-surgical meningitis due to multidrug resistant A. baumannii which were successfully treated with high-dose intravenous meropenem therapy.

Conclusions: Multidrug resistant Acinetobacter spp. in intensive care units are a growing concern. High-dose meropenem is used in the treatment of these infections.

Publication types

  • Case Reports

MeSH terms

  • Acinetobacter Infections / drug therapy*
  • Acinetobacter baumannii / drug effects*
  • Anti-Bacterial Agents / therapeutic use*
  • Drug Resistance, Multiple, Bacterial / drug effects
  • Female
  • Humans
  • Male
  • Meningitis, Bacterial / drug therapy*
  • Meningitis, Bacterial / microbiology
  • Meropenem
  • Microbial Sensitivity Tests
  • Middle Aged
  • Thienamycins / therapeutic use*

Substances

  • Anti-Bacterial Agents
  • Thienamycins
  • Meropenem